Gossamer Bio, Inc. (GOSS) Financial Statements (2026 and earlier)

Company Profile

Business Address 3115 MERRYFIELD ROW
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments136,932294,518296,425255,678325,218512,628
Cash and cash equivalent37,73246,07432,109111,973183,403486,055
Short-term investments99,200248,444264,316143,705141,81526,573
Restricted cash and investments     64565
Receivables12,2275,538    
Other undisclosed current assets18,4859,83210,0946,2026,4989,129
Total current assets:167,644309,888306,519261,880331,780522,322
Noncurrent Assets
Operating lease, right-of-use asset4,1335,1113,1315,9095,47710,550
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization64101,6483,9815,3205,534
Other noncurrent assets4082836186801,0801,027
Total noncurrent assets:4,6055,4045,39710,57011,87717,111
TOTAL ASSETS:172,249315,292311,916272,450343,657539,433
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,78617,50532,20621,99123,65428,219
Accounts payable5,9592,3195,5261,4593,2447,508
Accrued liabilities15,82715,18626,68020,53220,41020,711
Deferred revenue19,98717,050    
Debt   11,61311,613  
Other undisclosed current liabilities21,66210,4557,77915,62616,20510,431
Total current liabilities:63,43545,01051,59849,23039,85938,650
Noncurrent Liabilities
Long-term debt and lease obligation   81411,98832,29736,457
Long-term debt, excluding current maturities   81411,98829,07928,744
Liabilities, other than long-term debt33,06643,2671443,446  
Deferred revenue29,60638,869    
Operating lease, liability3,4604,3981443,4463,2187,713
Other undisclosed noncurrent liabilities198,508197,523196,591195,709146,820143,642
Total noncurrent liabilities:231,574240,790197,549211,143182,335180,099
Total liabilities:295,009285,800249,147260,373222,194218,749
Equity
Equity, attributable to parent(122,760)29,49262,76912,077121,463320,684
Common stock2423231088
Additional paid in capital1,321,3031,296,8481,275,1361,044,864932,944897,607
Accumulated other comprehensive income (loss)(5,149)1,189(350)(574)45599
Accumulated deficit(1,438,938)(1,268,568)(1,212,040)(1,032,223)(811,534)(577,530)
Total equity:(122,760)29,49262,76912,077121,463320,684
TOTAL LIABILITIES AND EQUITY:172,249315,292311,916272,450343,657539,433

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues48,471114,701   256
Realized investment gains 5    256
Gross profit:48,471114,701   256
Operating expenses(219,199)(174,620)(183,759)(218,593)(216,124)(233,962)
Other undisclosed operating loss      (256)
Operating loss:(170,728)(59,919)(183,759)(218,593)(216,124)(233,962)
Nonoperating income (expense)2704,2843,9423,0951,5603,268
Investment income, nonoperating1,9701,7791,9971,5837613,442
Other nonoperating income (expense)9,28914,02215,4561,512799(174)
Interest and debt expense(10,989)(11,517)(13,511)(13,880)(19,440)(12,666)
Loss from continuing operations before equity method investments, income taxes:(181,447)(67,152)(193,328)(229,378)(234,004)(243,360)
Other undisclosed income from continuing operations before income taxes10,98911,51713,51988 
Loss from continuing operations before income taxes:(170,458)(55,635)(179,809)(229,370)(233,996)(243,360)
Income tax expense (benefit) 88(893)    
Other undisclosed income from continuing operations      
Loss from continuing operations:(170,370)(56,528)(179,809)(229,370)(233,996)(243,360)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(233,996)(243,360)
Other undisclosed net income (loss)  (8)(8)(8) 
Net loss available to common stockholders, diluted:(170,370)(56,528)(179,817)(229,378)(234,004)(243,360)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(170,370)(56,528)(179,817)(229,378)(234,004)(243,360)
Comprehensive loss:(170,370)(56,528)(179,817)(229,378)(234,004)(243,360)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6,338)1,539224(619)(554)341
Comprehensive loss, net of tax, attributable to parent:(176,708)(54,989)(179,593)(229,997)(234,558)(243,019)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: